Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...

Living in food deserts, clinical trial deserts, and areas with high transportation vulnerability significantly lowers breast ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer ...

Cancer is the third leading cause of death in Kenya, after infectious and cardiovascular diseases.1 According to the National Institutes of Health, 50% of all cancer patients receive radiotherapy as ...

We read with interest the thoughtful Correspondence from François Bompart and colleagues1 expressing disappointment that the recent revisions to the Declaration of Helsinki (DoH) lacked specific and ...

New Ipsos data shows that while 58% of UK adults are willing to join clinical trials, this drops to 41% among ethnic minority ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer Network (NCCN), shares insights on the complex barriers limiting cancer patient ...

For many patients grappling with serious health conditions like ALS (Amyotrophic Lateral Sclerosis), the search for effective ...

The global Clinical Trials market is valued at USD 126.4 billion in 2025 and is projected to reach USD 192.6 billion by 2035, growing at a steady 4.3% CAGR. Demand is being driven by the resurgence of ...

Some patients reported participation in decision-making ... The IMA-cRCT is a low-intervention clinical trial where groups of subjects are allocated to the intervention groups and which satisfies all ...

Participation in a cervical cancer screening program in a safety-net health system more than doubled when patients received ...

Bowen, A. and Nargundkar, S. (2025) Transformational Strategies to Improve the Clinical Trial and Drug Development Process.